Drawing for RECOR MEDICAL

USPTO serial 90979028

RECOR MEDICAL

Reviewed by CopyMark Law Group

Reg. 6987531Status 700Registered
Filing date
Status date
Registration date
Feb 21, 2023
Examiner
SULLIVAN, JOHN C
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with RECOR MEDICAL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Sarah Otte Graber

Sarah Otte Graber Wood, Herron & Evans, LLP441 VINE STREET2700 Carew TowerCINCINNATI, OH 45202

Goods and services

ClassDescriptionStatusFirst use
009Signal generators for use with medical devices; connection cables for use with medical devicesACTIVE—
010Medical apparatus and instruments for renal denervation, treating and reducing hypertension, controlling blood pressure; Medical device systems consisting of medical devices for renal denervation, treating and reducing hypertension, controlling blood pressure; ultra-sound-emitting catheters used to perform denervation in human beings; medical devices for treating hypertension; medical devices used to perform denervation; medical device systems consisting of devices used in a medical setting to perform intravascular denervation; Medical device systems for use in renal denervation and other forms of neuromodulation of the autonomic nervous system, consisting of medical devices, catheters, electrical generators, plastic cartridges for medical fluids, connection cables for medical devices for use in performing denervation of human beings; ultrasound renal denervation systems consisting of medical devices for renal denervation; energy emitting catheter-based systems consisting of medical devices and devices for medical procedures in the nature of neuromodulation and denervation of the autonomic nervous system for use in treating a variety of medical conditions, including hypertension, among other medical conditions and also consisting of catheters, electrical generators, plastic cartridges for medical fluids, connection cables for medical devices used in connection with the preceding systems and devicesACTIVE—
016printed training materials in the field of healthcare; patient diary and study and patient participation and clinical trial materials, namely, printed patient questionnaires, patient disclosure forms, letters and brochuresACTIVE—
041Education, namely, training in the use and operation of medical and surgical equipment, apparatus and appliances and instruments, and consultation relating to the selection and use thereof to provide medical care, medical therapy and surgeryACTIVEJan 7, 2016
042Medical research services; providing an online computer database, namely, a repository of information in the field of medical clinical studies and medical research via medical case studies, peer-reviewed medical journal articles and medical referencesACTIVE—
044Providing medical information, consultancy and advisory services; professional consultation in the field of the use of medical and surgical equipment, apparatus, appliance and instruments; consultation on medical care, medical therapy and surgery; consultation services, namely, providing medical information to medical professionals to assist in the diagnosis and treatment of patients; medical consultation with physicians regarding the use of medical apparatus for treatment of patients; technical consultation in the field of medical and surgical equipment, apparatus, appliances and instruments, namely, consultation regarding their use in providing medical care, medical therapy and surgery; providing a patient support program, namely, providing medical information to patients evaluating therapeutic treatment options; providing medical information to patients in the field of surgery preparation; providing an on-line computer database, namely, a repository of information in the field of medical information and healthcare information accessible to healthcare providers including case studies, peer-reviewed journal articles and references; providing online medical evaluation services, namely, functional assessment program for patients who are about to receive medical treatment services for purposes of guiding treatment and assessing program effectiveness; home health care services in the nature of interactive medical care monitoring for patients; managed healthcare services, namely, providing disease management programs to others; consultation relating to the use of medical and surgical equipment, apparatus and appliances and instruments in medical care, medical therapy and surgeryACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 21, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Feb 21, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 20, 2023SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Jan 19, 2023CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Jan 19, 2023SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Jan 19, 2023DPCCDIVISIONAL PROCESSING COMPLETE—
Jan 12, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 12, 2023INCDITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST—
Jan 6, 2023AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Dec 7, 2022IUAFUSE AMENDMENT FILED—
Dec 7, 2022ERTDTEAS REQUEST TO DIVIDE RECEIVED—
Dec 7, 2022EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Nov 21, 2022DRRRDIVISIONAL REQUEST RECEIVED—
Jun 7, 2022NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 12, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 12, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 23, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 4, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 4, 2022XAECEXAMINER'S AMENDMENT ENTERED—
Mar 4, 2022GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 4, 2022GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 4, 2022CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 4, 2022ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Feb 15, 2022PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Feb 1, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 1, 2022XAECEXAMINER'S AMENDMENT ENTERED—
Feb 1, 2022GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Feb 1, 2022GNEAEXAMINERS AMENDMENT E-MAILED—
Feb 1, 2022CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 29, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 28, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 28, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 28, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 28, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 28, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 28, 2021GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 28, 2021GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 28, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 26, 2021DOCKASSIGNED TO EXAMINER—
Apr 17, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 21, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance